Abstract
Background
The assessment of psoriasis severity is complex and involves both the physical and psychologic assessment of the individual patient.Objective
We compared the Salford Psoriasis Index and several other tools for assessing psoriasis severity for their abilities to assess both the physical and psychologic effects of psoriasis.Methods
A total of 101 patients (44 women, 57 men) were assessed by means of the Salford Psoriasis Index (SPI), Psoriasis Area and Severity Index (PASI), Self-Administered PASI (SAPASI), Psoriasis Disability Index (PDI), Hospital Anxiety and Depression Scale (HADS), and Illness Perception Questionnaire (IPQ).Results
The "signs" score of SPI (which measures the clinical extent of psoriasis), PASI, and SAPASI correlated well with each other (r = 0.69-0.99; P <.01). They also correlated significantly, but not as strongly, with scores of psoriasis-induced disability, the PDI and SPI "psychosocial disability" score (r = 0.46-0.51; P <.01), but not with general measures of psychologic distress. There was no significant correlation between the historical treatment, "intervention," score in SPI and either the physical or the psychologic score in the SPI. The PDI and "psychosocial disability" score of SPI correlated well with each other (r = 0.69; P <.01) as well as with the depression and anxiety subscale scores of HADS (r = 0.33 and r = 0.37; P <.01, respectively), the total number of symptoms suffered by the patient (r = 0.38; P <.01), and the belief that stress or worry were associated with psoriasis (r = 0.33; P <.01).Conclusion
Physical scores of psoriasis severity such as PASI, SAPASI, and the "signs" component of SPI give a partial indication of psychosocial disability caused by psoriasis. In many patients, however, the physical score does not reflect psychosocial disability. Patients should be assessed by a more holistic approach, which takes into account both physical and psychologic measurements, such as used in SPI, when assessing the severity of psoriasis.References
Articles referenced by this article (17)
The outcomes movement and new measures of the severity of psoriasis.
J Am Acad Dermatol, (3):534-538 1996
MED: 8609278
Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory.
J Psychosom Res, (5):467-475 1997
MED: 9194019
Validation of Sickness Impact Profile and Psoriasis Disability Index in Psoriasis.
Br J Dermatol, (6):751-756 1990
MED: 2265090
Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
Br J Dermatol, (5):755-760 1997
MED: 9415236
The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures.
Br J Dermatol, (5):887-890 1999
MED: 10354027
The Salford Psoriasis Index: an holistic measure of psoriasis severity.
Br J Dermatol, (4):728-732 2000
MED: 10792223
The self-administered psoriasis area and severity index is valid and reliable.
J Invest Dermatol, (1):183-186 1996
MED: 8592072
Comparison of the General Health Questionnaire and the Hospital Anxiety and Depression Scale.
Br J Psychiatry, 860-864 1990
MED: 2289095
Show 7 more references (10 of 17)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1067/mjd.2001.114592
Article citations
How important is subjective well-being for patients? A qualitative interview study of people with psoriasis.
Qual Life Res, 31(12):3355-3363, 10 Aug 2022
Cited by: 1 article | PMID: 35948788 | PMCID: PMC9587968
Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment.
Curr Res Pharmacol Drug Discov, 2:100041, 09 Jun 2021
Cited by: 5 articles | PMID: 34909670 | PMCID: PMC8663928
Review Free full text in Europe PMC
Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study.
J Am Acad Dermatol, 81(4):923-930, 01 Jun 2019
Cited by: 5 articles | PMID: 31163241 | PMCID: PMC6746579
Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology Symptoms.
Int J Behav Med, 24(4):563-570, 01 Aug 2017
Cited by: 11 articles | PMID: 27924553
Psychiatric disorders, acne and systemic retinoids: comparison of risks.
Expert Opin Drug Saf, 16(9):989-995, 12 Jul 2017
Cited by: 4 articles | PMID: 28657366
Go to all (85) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
The psoriasis disability index in Chinese patients: contribution of clinical and psychological variables.
Int J Dermatol, 44(11):925-929, 01 Nov 2005
Cited by: 19 articles | PMID: 16336525
Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
Br J Dermatol, 137(5):755-760, 01 Nov 1997
Cited by: 161 articles | PMID: 9415236
Suffering in psoriasis patients: its relation with illness severity and subjective well-being.
Int J Dermatol, 46(10):1042-1045, 01 Oct 2007
Cited by: 17 articles | PMID: 17910711
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature.
J Eur Acad Dermatol Venereol, 24 Suppl 2:10-16, 01 Apr 2010
Cited by: 113 articles | PMID: 20443995
Review